The FDA asks for more information from Bristol-Myers Squibb (BMY -6%) and Pfizer (PFE -2.6%) about their new-drug application for Eliquis, which helps prevent strokes in patients with nonvalvular atrial fibrillation. The FDA wants an update on data management and verification from a study of the treatment, although the agency hasn't asked for a new trial.
Market Data 
Markets 
AI
